IL10 and rheumatoid arthritis: L. fermentum PC1 has a treatment potential against rheumatoid arthritis in the murine model of collagen-induced arthritis through the attenuation of proinflammatory cytokine IL-12 and the augmentation of anti-inflammatory cytokines IL-4 and IL-10 [30].